Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


TB043 Tuberculosis Study – A BCG challenge study in healthy adults to help develop TB vaccines.  If you are aged 18-50, in good health, and have never received the BCG vaccine, you may be eligible to participate.  The study involves 9-12 visits over a period of around 6 months. Participants will be reimbursed for their time and travel from £705 to £750.

Click here for more information. 



RVF001 Rift Valley Fever Vaccine Study - A phase I study to determine the safety and immunogenicity of the Rift Valley Fever (RVF) vaccine in healthy adult participants.  If you are aged 18-50 and are in good health, you may be eligible to participate.  The trial will involve 8 visits over a period of 3 months and participants will receive around £370 on completion of the study. 

Click here for more information.

EBL07 Ebola Vaccine Study

Using the same technology we used for the Oxford/AstraZeneca COVID-19 vaccine, Prof Teresa Lambe’s team at the Jenner Institute is conducting a study of a new Ebola vaccine that targets the two deadliest Ebolavirus species.

Why Are We Conducting This Study?

The study will help us learn more about the safety and tolerability of ChAdOx1 BiEBOV vaccine in healthy volunteers.

How will I be Making a Difference?

It is hoped that the information gained from this study will contribute to the development of a further safe and effective vaccine to protect at-risk populations from Ebola virus disease.

How do I get involved?

If you are 18-55 years old you may be eligible to participate.

You will be compensated approximately £370 for your time, travel and inconvenience.

Click here for more information. 

HIV Vaccine Study

HIV-CORE 0051 - A study to assess new candidate HIV vaccines in healthy adults: Are you aged 18-65 and in good health? You may be eligible to participate in our trial testing new vaccines against HIV. The trial will involve 13 visits over a period of 8 months and participants will receive up to £515 on completion of the study. 

Click here for more information. 


COVID-19 Vaccine development

For information about COV001 and COV002 COVID-19 Oxford Vaccine studies, please visit: Recruitment for these studies is now complete. 


Would you like to keep up to date with trials?

If you would like to register with us to receive our monthly email newsletter detailing our latest trials looking for volunteers, please click here.